First plaintiff in Zantac litigation drops suit against drug manufacturers
The first plaintiff scheduled to go to trial against drug manufacturers for the heartburn medication Zantac Tuesday dropped his suit. Joseph Bayer, who claimed Zantac (also known as ranitidine) caused him to develop esophageal cancer, told the court and drug manufacturers that he intended to file a notice of voluntary dismissal. Notably, there was no settlement [...]